The inaugural meeting of the Next Gen Sequencing working group took place on January 24th. Over 30 individuals attended to discuss the needs of the university for next gen sequencing from library preparation to result analysis.
For the next meeting Andi Broka will present on the LinGA High Performance Compute Cluster and its analytical capabilities and software resources. Additionally, a survey will be prepared to help categorize the university’s needs to help guide the future direction of the working group.
If you are interested in joining the working group, please email firstname.lastname@example.org to be added to the email list for future events and opportunities.
Next Gen Sequencing Working Group
Computational Resources at BU
Speaker: Andi Broka
February 15th, 3pm-4pm
EBRC Rm X714
650 Albany St
The Green High Performance Computing Center (GHPCC): How Will It Impact Research Computing at BUMC ?
On November 30, John Goodhue, Glenn Bresnahan, and Tracy Shroeder came to BUMC to discuss the Massachusetts Green High Performance Computer Center. This new initiative from five universities wil help keep Boston at the cutting edge of computational research.
For those who were not able to attend the meeting in person or online, you can download the slides from the presentation below.
Update: The slides from the meeting have been taken down. If you would like to discuss the GHPCC initiative, please contact email@example.com.
“Scientists, including a Boston University School of Public Health (BUSPH) researcher, have discovered 30 new genes that control the age of sexual maturation in women. Notably, many of these genes also act on body weight regulation or biological pathways related to fat metabolism.
The study, which appears in Nature Genetics, was co-authored by Kathryn Lunetta, a BUSPH professor of biostatistics. The study was a collaborative effort by the international ReproGen consortium, which included 175 scientists from 104 worldwide institutions, including Boston University School of Medicine (BUSM) and BUSPH.” ~From BU School of Public Health: The Insider
For the full article, please visit The Insider’s website.
From Art Jahnke, BU Today~
“The National Research Council has raised concerns in a letter posted on its website yesterday about the methodology used in an ongoing study of the risks associated with the National Emerging Infectious Diseases Laboratories (NEIDL) on the Boston University Medical Campus.
The NRC found that the risk assessment, which is being supervised by the National Institutes of Health and conducted by the consultancy Tetra Tech, had yet to respond to a recommendation for tiered quantitative and qualitative analyses and that its researchers erred when they used expert opinions as a substitute for absence of actual data on 13 pathogens in a modeling process. The NRC committee, whose concerns stem from a scheduled review of a preliminary draft of the risk assessment, urged Tetra Tech to make a “midcourse correction” and use actual data rather than the opinions of experts.”
For the full article, please visit BU Today.
The 2nd Annual GSI Research Symposium has come and gone this October. Hundreds of faculty, staff, and students stopped by the Heibert Lounge to support genetic and genomic research at Boston University.
Dozens of posters lined the walls of the 14th floor of the L-Building on the Medical Campus. Graduate and undergraduate students as well as postdoctoral fellows and faculty were all presenting posters.
Awards were given out to the best student and postdoctoral fellow presenters in multiple categories.
The GSI Symposium Awards Recipients: (top row) Elizabeth Tanner, Badri Vardarajan, Stephanie Correa, Rebecca Kusko, Constantina Christodoulou, Kristen Ott, Stephanie Schneider, Daniel Dworkis; (front row) Catalina Perdomo, Irene Degano, Stephanie van Veen, Cody MacDonald.
Click below to read about Adrienne’s selection as the most recent recipient of the Janet L. Norwood award.
GSI members along with other faculty at Boston University have collaborated to identify genes that can predict longevity. “The scientists, lead by Paola Sebastiani at the School of Public Health and Thomas Perls at the School of Medicine, have found 150 genetic markers that predict with 77 percent accuracy whether people will live extremely long lives” writes Boston University’s Rich Barlow and Lisa Chedekel.
For the full story, please visit BU Today here.
Held last Tuesday, June 15th, in the Evans Biomedical Research Center, the GSI Faculty Meeting was quite a success. For those of you who were unable to attend and share your thoughts on the future evolution of genetics and genomics at BU with us, you can find the slides from the presentation here. Any comments or suggestions can be directed to firstname.lastname@example.org.
GSI Member, Robert Green will be a guest speaker at two prominent events this June: The World Science Festival in New York and the Consumer Genetics Conference at the Hynes Convention Center in Boston. Below is the description of Dr. Green’s discussion at the World Science Festival.
“There is a revolution underway in the world of medicine. As researchers identify the genetic variants responsible for cancer, schizophrenia and diabetes, and doctors tailor medications and diagnostic tests specifically for your genomic makeup, we inch closer to personalized medicine. But what does this mean for you today? And how will it impact your health care ten, 20 or 30 years in the future? Join scientists standing on the leading edge of genomics to learn the promise, pitfalls, and realities barreling toward us.” – WSF Website
Led by GSI member Avi Spira, researchers from Boston University School of Medicine (BUSM) in collaboration with investigators at the University of Utah, have discovered a new approach for identifying smokers at the highest risk for developing lung cancer. The findings, which appear in the April 7th issue of Science Translational Medicine, will allow the researchers to use a genomic approach to prevent lung cancer in these individuals and to personalize cancer chemoprophylaxis and therapy. To read more about Spira’s discovery click here, or you can view the full published article: Gustafson, AM et al “Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development” Sci Transl Med 7 April 2010: Vol. 2, Issue 26, p. 26ra25